VSIR and neoplasm: T cell-specific PCPB1 deletion in mouse tumor models caused Treg differentiation and the induction of multiple checkpoint molecules including PD-1, TIGIT, and VISTA on tumor-infiltrating lymphocytes and reduced anti-tumor immunity [158].